MALAT1 long non-coding RNA in cancer

Biochimica et Biophysica Acta - Gene Regulatory Mechanisms

Volumn 1859, Issue 1, 2016, Pages 192-199

  Yoshimoto, Rei ^a,b   Mayeda, Akila ^a   Yoshida, Minoru ^b   Nakagawa, Shinichi ^b  

^a FUJITA HEALTH UNIVERSITY   (Japan)

^b RIKEN   (Japan)

Author keywords

Cancer; MALAT1; Noncoding RNA; Splicing

Indexed keywords

LONG UNTRANSLATED RNA; METASTASIS ASSOCIATED LUNG ADENOCARCINOMA TRANSCRIPT 1; UNCLASSIFIED DRUG; MALAT1 LONG NON-CODING RNA, HUMAN;

ALTERNATIVE RNA SPLICING; ARTICLE; BLADDER CARCINOMA; BREAST CANCER; COLON CANCER; DISEASE ASSOCIATION; ENDOMETRIUM CANCER; ESOPHAGUS CANCER; GENETIC TRANSCRIPTION; HUMAN; HYPOPHYSIS ADENOMA; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG CANCER; MOLECULAR PATHOLOGY; MULTIPLE MYELOMA; NEOPLASM; NEUROBLASTOMA; NONHUMAN; OSTEOSARCOMA; OVARY CANCER; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN MODIFICATION; STOMACH CANCER; TRANSCRIPTION REGULATION; TUMOR GENE; UTERINE CERVIX CANCER; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; PATHOLOGY;

ALTERNATIVE SPLICING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOPLASMS; RNA, LONG NONCODING; TRANSCRIPTION, GENETIC;

EID: 84953350072     PISSN: 18749399     EISSN: 18764320     Source Type: Journal    
DOI: 10.1016/j.bbagrm.2015.09.012     Document Type: Article

References (108)

1. Liang F., Holt I., Pertea G., Karamycheva S., Salzberg S.L., Quackenbush J. Gene index analysis of the human genome estimates approximately 120,000 genes. Nat. Genet. 2000, 25:239-240.
2. Kapranov P., Cawley S.E., Drenkow J., Bekiranov S., Strausberg R.L., Fodor S.P., Gingeras T.R. Large-scale transcriptional activity in chromosomes 21 and 22. Science 2002, 296:916-919.
3. Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N., Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K., Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M., Davis M.J., Wilming L.G., Aidinis V., Allen J.E., Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L., Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M., Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R., Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G., di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G., Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M., Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E., Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N., Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T., Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H., Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K., Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J., Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L., Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K., Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P., Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O., Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G., Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M., Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C., Schonbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y., Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B., Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K., Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A., Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K., Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C., Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J., Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y., Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T., Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N., Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N., Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S., Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J., Hayashizaki Y., Consortium F., R.G.E.R.Group, G.Genome Science The transcriptional landscape of the mammalian genome. Science 2005, 309:1559-1563.
4. Okazaki Y., Furuno M., Kasukawa T., Adachi J., Bono H., Kondo S., Nikaido I., Osato N., Saito R., Suzuki H., Yamanaka I., Kiyosawa H., Yagi K., Tomaru Y., Hasegawa Y., Nogami A., Schonbach C., Gojobori T., Baldarelli R., Hill D.P., Bult C., Hume D.A., Quackenbush J., Schriml L.M., Kanapin A., Matsuda H., Batalov S., Beisel K.W., Blake J.A., Bradt D., Brusic V., Chothia C., Corbani L.E., Cousins S., Dalla E., Dragani T.A., Fletcher C.F., Forrest A., Frazer K.S., Gaasterland T., Gariboldi M., Gissi C., Godzik A., Gough J., Grimmond S., Gustincich S., Hirokawa N., Jackson I.J., Jarvis E.D., Kanai A., Kawaji H., Kawasawa Y., Kedzierski R.M., King B.L., Konagaya A., Kurochkin I.V., Lee Y., Lenhard B., Lyons P.A., Maglott D.R., Maltais L., Marchionni L., McKenzie L., Miki H., Nagashima T., Numata K., Okido T., Pavan W.J., Pertea G., Pesole G., Petrovsky N., Pillai R., Pontius J.U., Qi D., Ramachandran S., Ravasi T., Reed J.C., Reed D.J., Reid J., Ring B.Z., Ringwald M., Sandelin A., Schneider C., Semple C.A., Setou M., Shimada K., Sultana R., Takenaka Y., Taylor M.S., Teasdale R.D., Tomita M., Verardo R., Wagner L., Wahlestedt C., Wang Y., Watanabe Y., Wells C., Wilming L.G., Wynshaw-Boris A., Yanagisawa M., Yang I., Yang L., Yuan Z., Zavolan M., Zhu Y., Zimmer A., Carninci P., Hayatsu N., Hirozane-Kishikawa T., Konno H., Nakamura M., Sakazume N., Sato K., Shiraki T., Waki K., Kawai J., Aizawa K., Arakawa T., Fukuda S., Hara A., Hashizume W., Imotani K., Ishii Y., Itoh M., Kagawa I., Miyazaki A., Sakai K., Sasaki D., Shibata K., Shinagawa A., Yasunishi A., Yoshino M., Waterston R., Lander E.S., Rogers J., Birney E., Hayashizaki Y., Consortium F., R.G.E.R.G.P.I, I.I.Team Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. Nature 2002, 420:563-573.
5. Consortium E.P. An integrated encyclopedia of DNA elements in the human genome. Nature 2012, 489:57-74.
6. E.P. Consortium, E. Birney, J.A. Stamatoyannopoulos, A. Dutta, R. Guigo, T.R. Gingeras, E.H. Margulies, Z. Weng, M. Snyder, E.T. Dermitzakis, R.E. Thurman, M.S. Kuehn, C.M. Taylor, S. Neph, C.M. Koch, S. Asthana, A. Malhotra, I. Adzhubei, J.A. Greenbaum, R.M. Andrews, P. Flicek, P.J. Boyle, H. Cao, N.P. Carter, G.K. Clelland, S. Davis, N. Day, P. Dhami, S.C. Dillon, M.O. Dorschner, H. Fiegler, P.G. Giresi, J. Goldy, M. Hawrylycz, A. Haydock, R. Humbert, K.D. James, B.E. Johnson, E.M. Johnson, T.T. Frum, E.R. Rosenzweig, N. Karnani, K. Lee, G.C. Lefebvre, P.A. Navas, F. Neri, S.C. Parker, P.J. Sabo, R. Sandstrom, A. Shafer, D. Vetrie, M. Weaver, S. Wilcox, M. Yu, F.S. Collins, J. Dekker, J.D. Lieb, T.D. Tullius, G.E. Crawford, S. Sunyaev, W.S. Noble, I. Dunham, F. Denoeud, A. Reymond, P. Kapranov, J. Rozowsky, D. Zheng, R. Castelo, A. Frankish, J. Harrow, S. Ghosh, A. Sandelin, I.L. Hofacker, R. Baertsch, D. Keefe, S. Dike, J. Cheng, H.A. Hirsch, E.A. Sekinger, J. Lagarde, J.F. Abril, A. Shahab, C. Flamm, C. Fried, J. Hackermuller, J. Hertel, M. Lindemeyer, K. Missal, A. Tanzer, S. Washietl, J. Korbel, O. Emanuelsson, J.S. Pedersen, N. Holroyd, R. Taylor, D. Swarbreck, N. Matthews, M.C. Dickson, D.J. Thomas, M.T. Weirauch, J. Gilbert, J. Drenkow, I. Bell, X. Zhao, K.G. Srinivasan, W.K. Sung, H.S. Ooi, K.P. Chiu, S. Foissac, T. Alioto, M. Brent, L. Pachter, M.L. Tress, A. Valencia, S.W. Choo, C.Y. Choo, C. Ucla, C. Manzano, C. Wyss, E. Cheung, T.G. Clark, J.B. Brown, M. Ganesh, S. Patel, H. Tammana, J. Chrast, C.N. Henrichsen, C. Kai, J. Kawai, U. Nagalakshmi, J. Wu, Z. Lian, J. Lian, P. Newburger, X. Zhang, P. Bickel, J.S. Mattick, P. Carninci, Y. Hayashizaki, S. Weissman, T. Hubbard, R.M. Myers, J. Rogers, P.F. Stadler, T.M. Lowe, C.L. Wei, Y. Ruan, K. Struhl, M. Gerstein, S.E. Antonarakis, Y. Fu, E.D. Green, U. Karaoz, A. Siepel, J. Taylor, L.A. Liefer, K.A. Wetterstrand, P.J. Good, E.A. Feingold, M.S. Guyer, G.M. Cooper, G. Asimenos, C.N. Dewey, M. Hou, S. Nikolaev, J.I. Montoya-Burgos, A. Loytynoja, S. Whelan, F. Pardi, T. Massingham, H. Huang, N.R. Zhang, I. Holmes, J.C. Mullikin, A. Ureta-Vidal, B. Paten, M. Seringhaus, D. Church, K. Rosenbloom, W.J. Kent, E.A. Stone, N.C.S. Program, C. Baylor College of Medicine Human Genome Sequencing, C. Washington University Genome Sequencing, I. Broad, I. Children's Hospital Oakland Research, S. Batzoglou, N. Goldman, R.C. Hardison, D. Haussler, W. Miller, A. Sidow, N.D. Trinklein, Z.D. Zhang, L. Barrera, R. Stuart, D.C. King, A. Ameur, S. Enroth, M.C. Bieda, J. Kim, A.A. Bhinge, N. Jiang, J. Liu, F. Yao, V.B. Vega, C.W. Lee, P. Ng, A. Shahab, A. Yang, Z. Moqtaderi, Z. Zhu, X. Xu, S. Squazzo, M.J. Oberley, D. Inman, M.A. Singer, T.A. Richmond, K.J. Munn, A. Rada-Iglesias, O. Wallerman, J. Komorowski, J.C. Fowler, P. Couttet, A.W. Bruce, O.M. Dovey, P.D. Ellis, C.F. Langford, D.A. Nix, G. Euskirchen, S. Hartman, A.E. Urban, P. Kraus, S. Van Calcar, N. Heintzman, T.H. Kim, K. Wang, C. Qu, G. Hon, R. Luna, C.K. Glass, M.G. Rosenfeld, S.F. Aldred, S.J. Cooper, A. Halees, J.M. Lin, H.P. Shulha, X. Zhang, M. Xu, J.N. Haidar, Y. Yu, Y. Ruan, V.R. Iyer, R.D. Green, C. Wadelius, P.J. Farnham, B. Ren, R.A. Harte, A.S. Hinrichs, H. Trumbower, H. Clawson, J. Hillman-Jackson, A.S. Zweig, K. Smith, A. Thakkapallayil, G. Barber, R.M. Kuhn, D. Karolchik, L. Armengol, C.P. Bird, P.I. de Bakker, A.D. Kern, N. Lopez-Bigas, J.D. Martin, B.E. Stranger, A. Woodroffe, E. Davydov, A. Dimas, E. Eyras, I.B. Hallgrimsdottir, J. Huppert, M.C. Zody, G.R. Abecasis, X. Estivill, G.G. Bouffard, X. Guan, N.F. Hansen, J.R. Idol, V.V. Maduro, B. Maskeri, J.C. McDowell, M. Park, P.J. Thomas, A.C. Young, R.W. Blakesley, D.M. Muzny, E. Sodergren, D.A. Wheeler, K.C. Worley, H. Jiang, G.M. Weinstock, R.A. Gibbs, T. Graves, R. Fulton, E.R. Mardis, R.K. Wilson, M. Clamp, J. Cuff, S. Gnerre, D.B. Jaffe, J.L. Chang, K. Lindblad-Toh, E.S. Lander, M. Koriabine, M. Nefedov, K. Osoegawa, Y. Yoshinaga, B. Zhu, P.J. de Jong, Identification and analysis of functional elements in 1% of the human genome by the ENCODE pilot project, Nature, 447 (2007) 799-816.
7. Wang K.C., Chang H.Y. Molecular mechanisms of long noncoding RNAs. Mol. Cell 2011, 43:904-914.
8. Ulitsky I., Bartel D.P. lincRNAs: genomics, evolution, and mechanisms. Cell 2013, 154:26-46.
9. Ghildiyal M., Zamore P.D. Small silencing RNAs: an expanding universe. Nat. Rev. Genet. 2009, 10:94-108.
10. Kim V.N., Han J., Siomi M.C. Biogenesis of small RNAs in animals. Nat. Rev. Mol. Cell Biol. 2009, 10:126-139.
11. Ulitsky I., Shkumatava A., Jan C.H., Sive H., Bartel D.P. Conserved function of lincRNAs in vertebrate embryonic development despite rapid sequence evolution. Cell 2011, 147:1537-1550.
12. Ip J.Y., Nakagawa S. Long non-coding RNAs in nuclear bodies. Develop. Growth Differ. 2012, 54:44-54.
13. Gutschner T., Hammerle M., Diederichs S. MALAT1 - a paradigm for long noncoding RNA function in cancer. J. Mol. Med. (Berl.) 2013, 91:791-801.
14. Marx S.J. Molecular genetics of multiple endocrine neoplasia types 1 and 2. Nat. Rev. Cancer 2005, 5:367-375.
15. Ji P., Diederichs S., Wang W., Boing S., Metzger R., Schneider P.M., Tidow N., Brandt B., Buerger H., Bulk E., Thomas M., Berdel W.E., Serve H., Muller-Tidow C. MALAT-1, a novel noncoding RNA, and thymosin beta4 predict metastasis and survival in early-stage non-small cell lung cancer. Oncogene 2003, 22:8031-8041.
16. Hutchinson J.N., Ensminger A.W., Clemson C.M., Lynch C.R., Lawrence J.B., Chess A. A screen for nuclear transcripts identifies two linked noncoding RNAs associated with SC35 splicing domains. BMC Genomics 2007, 8:39.
17. Spector D.L., Lamond A.I. Nuclear Speckles. Cold Spring Harb. Perspect. Biol. 2011, 3.
18. Wilusz J.E., Freier S.M., Spector D.L. 3' end processing of a long nuclear-retained noncoding RNA yields a tRNA-like cytoplasmic RNA. Cell 2008, 135:919-932.
19. Wilusz J.E., JnBaptiste C.K., Lu L.Y., Kuhn C.D., Joshua-Tor L., Sharp P.A. A triple helix stabilizes the 3' ends of long noncoding RNAs that lack poly(A) tails. Genes Dev. 2012, 26:2392-2407.
20. Brown J.A., Valenstein M.L., Yario T.A., Tycowski K.T., Steitz J.A. Formation of triple-helical structures by the 3'-end sequences of MALAT1 and MENbeta noncoding RNAs. Proc. Natl. Acad. Sci. U. S. A. 2012, 109:19202-19207.
21. Brown J.A., Bulkley D., Wang J., Valenstein M.L., Yario T.A., Steitz T.A., Steitz J.A. Structural insights into the stabilization of MALAT1 noncoding RNA by a bipartite triple helix. Nat. Struct. Mol. Biol. 2014, 21:633-640.
22. Tani H., Mizutani R., Salam K.A., Tano K., Ijiri K., Wakamatsu A., Isogai T., Suzuki Y., Akimitsu N. Genome-wide determination of RNA stability reveals hundreds of short-lived noncoding transcripts in mammals. Genome Res. 2012, 22:947-956.
23. Tani H., Nakamura Y., Ijiri K., Akimitsu N. Stability of MALAT-1, a nuclear long non-coding RNA in mammalian cells, varies in various cancer cells. Drug Discov. Ther. 2010, 4:235-239.
24. Simon M.D., Wang C.I., Kharchenko P.V., West J.A., Chapman B.A., Alekseyenko A.A., Borowsky M.L., Kuroda M.I., Kingston R.E. The genomic binding sites of a noncoding RNA. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:20497-20502.
25. Miyagawa R., Tano K., Mizuno R., Nakamura Y., Ijiri K., Rakwal R., Shibato J., Masuo Y., Mayeda A., Hirose T., Akimitsu N. Identification of cis- and trans-acting factors involved in the localization of MALAT-1 noncoding RNA to nuclear speckles. RNA 2012, 18:738-751.
26. Tripathi V., Ellis J.D., Shen Z., Song D.Y., Pan Q., Watt A.T., Freier S.M., Bennett C.F., Sharma A., Bubulya P.A., Blencowe B.J., Prasanth S.G., Prasanth K.V. The nuclear-retained noncoding RNA MALAT1 regulates alternative splicing by modulating SR splicing factor phosphorylation. Mol. Cell 2010, 39:925-938.
27. Tripathi V., Shen Z., Chakraborty A., Giri S., Freier S.M., Wu X., Zhang Y., Gorospe M., Prasanth S.G., Lal A., Prasanth K.V. Long noncoding RNA MALAT1 controls cell cycle progression by regulating the expression of oncogenic transcription factor B-MYB. PLoS Genet. 2013, 9.
28. Schor I.E., Lleres D., Risso G.J., Pawellek A., Ule J., Lamond A.I., Kornblihtt A.R. Perturbation of chromatin structure globally affects localization and recruitment of splicing factors. PLoS One 2012, 7.
29. Anko M.L., Neugebauer K.M. Long noncoding RNAs add another layer to pre-mRNA splicing regulation. Mol. Cell 2010, 39:833-834.
30. Polymenidou M., Lagier-Tourenne C., Hutt K.R., Huelga S.C., Moran J., Liang T.Y., Ling S.C., Sun E., Wancewicz E., Mazur C., Kordasiewicz H., Sedaghat Y., Donohue J.P., Shiue L., Bennett C.F., Yeo G.W., Cleveland D.W. Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat. Neurosci. 2011, 14:459-468.
31. Tollervey J.R., Curk T., Rogelj B., Briese M., Cereda M., Kayikci M., Konig J., Hortobagyi T., Nishimura A.L., Zupunski V., Patani R., Chandran S., Rot G., Zupan B., Shaw C.E., Ule J. Characterizing the RNA targets and position-dependent splicing regulation by TDP-43. Nat. Neurosci. 2011, 14:452-458.
32. Macias S., Plass M., Stajuda A., Michlewski G., Eyras E., Caceres J.F. DGCR8 HITS-CLIP reveals novel functions for the microprocessor. Nat. Struct. Mol. Biol. 2012, 19:760-766.
33. Weinmann L., Hock J., Ivacevic T., Ohrt T., Mutze J., Schwille P., Kremmer E., Benes V., Urlaub H., Meister G. Importin 8 is a gene silencing factor that targets argonaute proteins to distinct mRNAs. Cell 2009, 136:496-507.
34. Anko M.L., Muller-McNicoll M., Brandl H., Curk T., Gorup C., Henry I., Ule J., Neugebauer K.M. The RNA-binding landscapes of two SR proteins reveal unique functions and binding to diverse RNA classes. Genome Biol. 2012, 13:R17.
35. Yang F., Yi F., Han X., Du Q., Liang Z. MALAT-1 interacts with hnRNP C in cell cycle regulation. FEBS Lett. 2013, 587:3175-3181.
36. Yang L., Lin C., Liu W., Zhang J., Ohgi K.A., Grinstein J.D., Dorrestein P.C., Rosenfeld M.G. ncRNA- and Pc2 methylation-dependent gene relocation between nuclear structures mediates gene activation programs. Cell 2011, 147:773-788.
37. Koshimizu T.A., Fujiwara Y., Sakai N., Shibata K., Tsuchiya H. Oxytocin stimulates expression of a noncoding RNA tumor marker in a human neuroblastoma cell line. Life Sci. 2010, 86:455-460.
38. Tee A.E., Ling D., Nelson C., Atmadibrata B., Dinger M.E., Xu N., Mizukami T., Liu P.Y., Liu B., Cheung B., Pasquier E., Haber M., Norris M.D., Suzuki T., Marshall G.M., Liu T. The histone demethylase JMJD1A induces cell migration and invasion by up-regulating the expression of the long noncoding RNA MALAT1. Oncotarget 2014, 5:1793-1804.
39. Fan Y., Shen B., Tan M., Mu X., Qin Y., Zhang F., Liu Y. TGF-beta-induced upregulation of malat1 promotes bladder cancer metastasis by associating with suz12. Clin. Cancer Res. 2014, 20:1531-1541.
40. Zhao Y., Yang Y., Trovik J., Sun K., Zhou L., Jiang P., Lau T.S., Hoivik E.A., Salvesen H.B., Sun H., Wang H. A novel wnt regulatory axis in endometrioid endometrial cancer. Cancer Res. 2014, 74:5103-5117.
41. Zhao Z., Chen C., Liu Y., Wu C. 17beta-estradiol treatment inhibits breast cell proliferation, migration and invasion by decreasing MALAT-1 RNA level. Biochem. Biophys. Res. Commun. 2014, 445:388-393.
42. Fang D., Yang H., Lin J., Teng Y., Jiang Y., Chen J., Li Y. 17beta-estradiol regulates cell proliferation, colony formation, migration, invasion and promotes apoptosis by upregulating miR-9 and thus degrades MALAT-1 in osteosarcoma cell MG-63 in an estrogen receptor-independent manner. Biochem. Biophys. Res. Commun. 2015, 457:500-506.
43. Kuo I.Y., Wu C.C., Chang J.M., Huang Y.L., Lin C.H., Yan J.J., Sheu B.S., Lu P.J., Chang W.L., Lai W.W., Wang Y.C. Low SOX17 expression is a prognostic factor and drives transcriptional dysregulation and esophageal cancer progression. Int. J. Cancer 2014, 135:563-573.
44. Michalik K.M., You X., Manavski Y., Doddaballapur A., Zornig M., Braun T., John D., Ponomareva Y., Chen W., Uchida S., Boon R.A., Dimmeler S. Long noncoding RNA MALAT1 regulates endothelial cell function and vessel growth. Circ. Res. 2014, 114:1389-1397.
45. Allen D.L., Hittel D.S., McPherron A.C. Expression and function of myostatin in obesity, diabetes, and exercise adaptation. Med. Sci. Sports Exerc. 2011, 43:1828-1835.
46. Watts R., Johnsen V.L., Shearer J., Hittel D.S. Myostatin-induced inhibition of the long noncoding RNA MALAT1 is associated with decreased myogenesis. Am. J. Physiol. Cell Physiol. 2013, 304:C995-1001.
47. Han Y., Liu Y., Zhang H., Wang T., Diao R., Jiang Z., Gui Y., Cai Z. Hsa-miR-125b suppresses bladder cancer development by down-regulating oncogene SIRT7 and oncogenic long non-coding RNA MALAT1. FEBS Lett. 2013, 587:3875-3882.
48. Leucci E., Patella F., Waage J., Holmstrom K., Lindow M., Porse B., Kauppinen S., Lund A.H. microRNA-9 targets the long non-coding RNA MALAT1 for degradation in the nucleus. Sci. Report. 2013, 3:2535.
49. Wang X., Li M., Wang Z., Han S., Tang X., Ge Y., Zhou L., Zhou C., Yuan Q., Yang M. Silencing of long noncoding RNA MALAT1 by miR-101 and miR-217 inhibits proliferation, Migration, and Invasion of Esophageal Squamous Cell Carcinoma Cells. J. Biol. Chem. 2015, 290:3925-3935.
50. Hirata H., Hinoda Y., Shahryari V., Deng G., Nakajima K., Tabatabai Z.L., Ishii N., Dahiya R. Long noncoding RNA MALAT1 promotes aggressive renal cell carcinoma through Ezh2 and interacts with miR-205. Cancer Res. 2015.
51. Buratti E., Baralle F.E. Characterization and functional implications of the RNA binding properties of nuclear factor TDP-43, a novel splicing regulator of CFTR exon 9. J. Biol. Chem. 2001, 276:36337-36343.
52. Arai T., Hasegawa M., Akiyama H., Ikeda K., Nonaka T., Mori H., Mann D., Tsuchiya K., Yoshida M., Hashizume Y., Oda T. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006, 351:602-611.
53. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006, 314:130-133.
54. Kabashi E., Valdmanis P.N., Dion P., Spiegelman D., McConkey B.J., Vande Velde C., Bouchard J.P., Lacomblez L., Pochigaeva K., Salachas F., Pradat P.F., Camu W., Meininger V., Dupre N., Rouleau G.A. TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat. Genet. 2008, 40:572-574.
55. Sreedharan J., Blair I.P., Tripathi V.B., Hu X., Vance C., Rogelj B., Ackerley S., Durnall J.C., Williams K.L., Buratti E., Baralle F., de Belleroche J., Mitchell J.D., Leigh P.N., Al-Chalabi A., Miller C.C., Nicholson G., Shaw C.E. TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 2008, 319:1668-1672.
56. Song X., Sui A., Garen A. Binding of mouse VL30 retrotransposon RNA to PSF protein induces genes repressed by PSF: effects on steroidogenesis and oncogenesis. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:621-626.
57. Liu N., Parisien M., Dai Q., Zheng G., He C., Pan T. Probing N6-methyladenosine RNA modification status at single nucleotide resolution in mRNA and long noncoding RNA. RNA 2013, 19:1848-1856.
58. Meyer K.D., Saletore Y., Zumbo P., Elemento O., Mason C.E., Jaffrey S.R. Comprehensive analysis of mRNA methylation reveals enrichment in 3' UTRs and near stop codons. Cell 2012, 149:1635-1646.
59. Squires J.E., Patel H.R., Nousch M., Sibbritt T., Humphreys D.T., Parker B.J., Suter C.M., Preiss T. Widespread occurrence of 5-methylcytosine in human coding and non-coding RNA. Nucleic Acids Res. 2012, 40:5023-5033.
60. Liu N., Dai Q., Zheng G., He C., Parisien M., Pan T. N(6)-methyladenosine-dependent RNA structural switches regulate RNA-protein interactions. Nature 2015, 518:560-564.
61. Lin R., Roychowdhury-Saha M., Black C., Watt A.T., Marcusson E.G., Freier S.M., Edgington T.S. Control of RNA processing by a large non-coding RNA over-expressed in carcinomas. FEBS Lett. 2011, 585:671-676.
62. Zhang B., Arun G., Mao Y.S., Lazar Z., Hung G., Bhattacharjee G., Xiao X., Booth C.J., Wu J., Zhang C., Spector D.L. The lncRNA MALAT1 is dispensable for mouse development but its transcription plays a cis-regulatory role in the adult. Cell Rep. 2012, 2:111-123.
63. Nakagawa S., Ip J.Y., Shioi G., Tripathi V., Zong X., Hirose T., Prasanth K.V. MALAT1 is not an essential component of nuclear speckles in mice. RNA 2012, 18:1487-1499.
64. Eissmann M., Gutschner T., Hammerle M., Gunther S., Caudron-Herger M., Gross M., Schirmacher P., Rippe K., Braun T., Zornig M., Diederichs S. Loss of the abundant nuclear non-coding RNA MALAT1 is compatible with life and development. RNA Biol. 2012, 9:1076-1087.
65. Gutschner T., Hammerle M., Eissmann M., Hsu J., Kim Y., Hung G., Revenko A., Arun G., Stentrup M., Gross M., Zornig M., MacLeod A.R., Spector D.L., Diederichs S. The noncoding RNA MALAT1 is a critical regulator of the metastasis phenotype of lung cancer cells. Cancer Res. 2013, 73:1180-1189.
66. Bregman D.B., Du L., van der Zee S., Warren S.L. Transcription-dependent redistribution of the large subunit of RNA polymerase II to discrete nuclear domains. J. Cell Biol. 1995, 129:287-298.
67. Mortillaro M.J., Blencowe B.J., Wei X., Nakayasu H., Du L., Warren S.L., Sharp P.A., Berezney R. A hyperphosphorylated form of the large subunit of RNA polymerase II is associated with splicing complexes and the nuclear matrix. Proc. Natl. Acad. Sci. U. S. A. 1996, 93:8253-8257.
68. Tano K., Mizuno R., Okada T., Rakwal R., Shibato J., Masuo Y., Ijiri K., Akimitsu N. MALAT-1 enhances cell motility of lung adenocarcinoma cells by influencing the expression of motility-related genes. FEBS Lett. 2010, 584:4575-4580.
69. West J.A., Davis C.P., Sunwoo H., Simon M.D., Sadreyev R.I., Wang P.I., Tolstorukov M.Y., Kingston R.E. The long noncoding RNAs NEAT1 and MALAT1 bind active chromatin sites. Mol. Cell 2014, 55:791-802.
70. Engreitz J.M., Sirokman K., McDonel P., Shishkin A.A., Surka C., Russell P., Grossman S.R., Chow A.Y., Guttman M., Lander E.S. RNA-RNA interactions enable specific targeting of noncoding RNAs to nascent Pre-mRNAs and chromatin sites. Cell 2014, 159:188-199.
71. Nakagawa S., Hirose T. Paraspeckle nuclear bodies-useful uselessness?. Cell. Mol. Life Sci. 2012, 69:3027-3036.
72. Engreitz J.M., Pandya-Jones A., McDonel P., Shishkin A., Sirokman K., Surka C., Kadri S., Xing J., Goren A., Lander E.S., Plath K., Guttman M. The Xist lncRNA exploits three-dimensional genome architecture to spread across the X chromosome. Science 2013, 341:1237973.
73. Li B., Chen P., Qu J., Shi L., Zhuang W., Fu J., Li J., Zhang X., Sun Y., Zhuang W. Activation of LTBP3 gene by a long noncoding RNA (lncRNA) MALAT1 transcript in mesenchymal stem cells from multiple myeloma. J. Biol. Chem. 2014, 289:29365-29375.
74. Lopez-Ayllon B.D., Moncho-Amor V., Abarrategi A., Ibanez de Caceres I., Castro-Carpeno J., Belda-Iniesta C., Perona R., Sastre L. Cancer stem cells and cisplatin-resistant cells isolated from non-small-lung cancer cell lines constitute related cell populations. Cancer Med. 2014, 3:1099-1111.
75. Weber D.G., Johnen G., Casjens S., Bryk O., Pesch B., Jockel K.H., Kollmeier J., Bruning T. Evaluation of long noncoding RNA MALAT1 as a candidate blood-based biomarker for the diagnosis of non-small cell lung cancer. BMC Res. Notes 2013, 6:518.
76. Yao Y., Fan Y., Wu J., Wan H., Wang J., Lam S., Lam W.L., Girard L., Gazdar A.F., Wu Z., Zhou Q. Potential application of non-small cell lung cancer-associated autoantibodies to early cancer diagnosis. Biochem. Biophys. Res. Commun. 2012, 423:613-619.
77. Han Y., Liu Y., Nie L., Gui Y., Cai Z. Inducing cell proliferation inhibition, apoptosis, and motility reduction by silencing long noncoding ribonucleic acid metastasis-associated lung adenocarcinoma transcript 1 in urothelial carcinoma of the bladder. Urology 2013, 81:e201-e207. 209.
78. Guffanti A., Iacono M., Pelucchi P., Kim N., Solda G., Croft L.J., Taft R.J., Rizzi E., Askarian-Amiri M., Bonnal R.J., Callari M., Mignone F., Pesole G., Bertalot G., Bernardi L.R., Albertini A., Lee C., Mattick J.S., Zucchi I., De Bellis G. A transcriptional sketch of a primary human breast cancer by 454 deep sequencing. BMC Genomics 2009, 10:163.
79. Ellis M.J., Ding L., Shen D., Luo J., Suman V.J., Wallis J.W., Van Tine B.A., Hoog J., Goiffon R.J., Goldstein T.C., Ng S., Lin L., Crowder R., Snider J., Ballman K., Weber J., Chen K., Koboldt D.C., Kandoth C., Schierding W.S., McMichael J.F., Miller C.A., Lu C., Harris C.C., McLellan M.D., Wendl M.C., DeSchryver K., Allred D.C., Esserman L., Unzeitig G., Margenthaler J., Babiera G.V., Marcom P.K., Guenther J.M., Leitch M., Hunt K., Olson J., Tao Y., Maher C.A., Fulton L.L., Fulton R.S., Harrison M., Oberkfell B., Du F., Demeter R., Vickery T.L., Elhammali A., Piwnica-Worms H., McDonald S., Watson M., Dooling D.J., Ota D., Chang L.W., Bose R., Ley T.J., Piwnica-Worms D., Stuart J.M., Wilson R.K., Mardis E.R. Whole-genome analysis informs breast cancer response to aromatase inhibition. Nature 2012, 486:353-360.
80. Jiang Y., Li Y., Fang S., Jiang B., Qin C., Xie P., Zhou G., Li G. The role of MALAT1 correlates with HPV in cervical cancer. Oncol. Lett. 2014, 7:2135-2141.
81. Guo F., Li Y., Liu Y., Wang J., Li Y., Li G. Inhibition of metastasis-associated lung adenocarcinoma transcript 1 in CaSki human cervical cancer cells suppresses cell proliferation and invasion. Acta Biochim. Biophys. Sin. (Shanghai) 2010, 42:224-229.
82. Kan J.Y., Wu D.C., Yu F.J., Wu C.Y., Ho Y.W., Chiu Y.J., Jian S.F., Hung J.Y., Wang J.Y., Kuo P.L. Chemokine (C-C motif) ligand 5 is involved in tumor-associated dendritic cell-mediated colon cancer progression through non-coding RNA MALAT-1. J. Cell. Physiol. 2014.
83. Zheng H.T., Shi D.B., Wang Y.W., Li X.X., Xu Y., Tripathi P., Gu W.L., Cai G.X., Cai S.J. High expression of lncRNA MALAT1 suggests a biomarker of poor prognosis in colorectal cancer. Int. J. Clin. Exp. Pathol. 2014, 7:3174-3181.
84. Xu C., Yang M., Tian J., Wang X., Li Z. MALAT-1: a long non-coding RNA and its important 3' end functional motif in colorectal cancer metastasis. Int. J. Oncol. 2011, 39:169-175.
85. Ji Q., Zhang L., Liu X., Zhou L., Wang W., Han Z., Sui H., Tang Y., Wang Y., Liu N., Ren J., Hou F., Li Q. Long non-coding RNA MALAT1 promotes tumour growth and metastasis in colorectal cancer through binding to SFPQ and releasing oncogene PTBP2 from SFPQ/PTBP2 complex. Br. J. Cancer 2014, 111:736-748.
86. Ji Q., Liu X., Fu X., Zhang L., Sui H., Zhou L., Sun J., Cai J., Qin J., Ren J., Li Q. Resveratrol inhibits invasion and metastasis of colorectal cancer cells via MALAT1 mediated Wnt/beta-catenin signal pathway. PLoS One 2013, 8.
87. Hu L., Wu Y., Tan D., Meng H., Wang K., Bai Y., Yang K. Up-regulation of long noncoding RNA MALAT1 contributes to proliferation and metastasis in esophageal squamous cell carcinoma. J. Exp. Clin. Cancer Res. 2015, 34:7.
88. Okugawa Y., Toiyama Y., Hur K., Toden S., Saigusa S., Tanaka K., Inoue Y., Mohri Y., Kusunoki M., Boland C.R., Goel A. Metastasis-associated long non-coding RNA drives gastric cancer development and promotes peritoneal metastasis. Carcinogenesis 2014, 35:2731-2739.
89. Lin R., Maeda S., Liu C., Karin M., Edgington T.S. A large noncoding RNA is a marker for murine hepatocellular carcinomas and a spectrum of human carcinomas. Oncogene 2007, 26:851-858.
90. Liu W.T., Lu X., Tang G.H., Ren J.J., Liao W.J., Ge P.L., Huang J.F. LncRNAs expression signatures of hepatocellular carcinoma revealed by microarray. World J. Gastroenterol. 2014, 20:6314-6321.
91. Liu Y., Pan S., Liu L., Zhai X., Liu J., Wen J., Zhang Y., Chen J., Shen H., Hu Z. A genetic variant in long non-coding RNA HULC contributes to risk of HBV-related hepatocellular carcinoma in a Chinese population. PLoS One 2012, 7.
92. Luo J.H., Ren B., Keryanov S., Tseng G.C., Rao U.N., Monga S.P., Strom S., Demetris A.J., Nalesnik M., Yu Y.P., Ranganathan S., Michalopoulos G.K. Transcriptomic and genomic analysis of human hepatocellular carcinomas and hepatoblastomas. Hepatology 2006, 44:1012-1024.
93. Mohamadkhani A. Long noncoding RNAs in interaction with RNA binding proteins in hepatocellular carcinoma. Hepat. Mon. 2014, 14.
94. Chaudhry M.A. Expression pattern of small nucleolar RNA host genes and long Non-coding RNA in X-rays-treated lymphoblastoid cells. Int. J. Mol. Sci. 2013, 14:9099-9110.
95. Li L., Feng T., Lian Y., Zhang G., Garen A., Song X. Role of human noncoding RNAs in the control of tumorigenesis. Proc. Natl. Acad. Sci. U. S. A. 2009, 106:12956-12961.
96. Cho S.F., Chang Y.C., Chang C.S., Lin S.F., Liu Y.C., Hsiao H.H., Chang J.G., Liu T.C. MALAT1 long non-coding RNA is overexpressed in multiple myeloma and may serve as a marker to predict disease progression. BMC Cancer 2014, 14:809.
97. Isin M., Ozgur E., Cetin G., Erten N., Aktan M., Gezer U., Dalay N. Investigation of circulating lncRNAs in B-cell neoplasms. Clin. Chim. Acta 2014, 431:255-259.
98. Taniguchi M., Fujiwara K., Nakai Y., Ozaki T., Koshikawa N., Toshio K., Kataba M., Oguni A., Matsuda H., Yoshida Y., Tokuhashi Y., Fukuda N., Ueno T., Soma M., Nagase H. Inhibition of malignant phenotypes of human osteosarcoma cells by a gene silencer, a pyrrole-imidazole polyamide, which targets an E-box motif. FEBS Open Bio 2014, 4:328-334.
99. Liu S.P., Yang J.X., Cao D.Y., Shen K. Identification of differentially expressed long non-coding RNAs in human ovarian cancer cells with different metastatic potentials. Cancer Biol. Med. 2013, 10:138-141.
100. Li Z., Li C., Liu C., Yu S., Zhang Y. Expression of the long non-coding RNAs MEG3, HOTAIR, and MALAT-1 in non-functioning pituitary adenomas and their relationship to tumor behavior. Pituitary 2015, 18:42-47.
101. Ren S., Liu Y., Xu W., Sun Y., Lu J., Wang F., Wei M., Shen J., Hou J., Gao X., Xu C., Huang J., Zhao Y., Sun Y. Long noncoding RNA MALAT-1 is a new potential therapeutic target for castration resistant prostate cancer. J. Urol. 2013, 190:2278-2287.
102. Sowalsky A.G., Xia Z., Wang L., Zhao H., Chen S., Bubley G.J., Balk S.P., Li W. Whole transcriptome sequencing reveals extensive unspliced mRNA in metastatic castration-resistant prostate cancer. Mol. Cancer Res. 2015, 13:98-106.
103. Wang F., Ren S., Chen R., Lu J., Shi X., Zhu Y., Zhang W., Jing T., Zhang C., Shen J., Xu C., Wang H., Wang H., Wang Y., Liu B., Li Y., Fang Z., Guo F., Qiao M., Wu C., Wei Q., Xu D., Shen D., Lu X., Gao X., Hou J., Sun Y. Development and prospective multicenter evaluation of the long noncoding RNA MALAT-1 as a diagnostic urinary biomarker for prostate cancer. Oncotarget 2014, 5:11091-11102.
104. Davis I.J., Hsi B.L., Arroyo J.D., Vargas S.O., Yeh Y.A., Motyckova G., Valencia P., Perez-Atayde A.R., Argani P., Ladanyi M., Fletcher J.A., Fisher D.E. Cloning of an alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc. Natl. Acad. Sci. U. S. A. 2003, 100:6051-6056.
105. Karni R., de Stanchina E., Lowe S.W., Sinha R., Mu D., Krainer A.R. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 2007, 14:185-193.
106. Song X., Wang B., Bromberg M., Hu Z., Konigsberg W., Garen A. Retroviral-mediated transmission of a mouse VL30 RNA to human melanoma cells promotes metastasis in an immunodeficient mouse model. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:6269-6273.
107. Song X., Sun Y., Garen A. Roles of PSF protein and VL30 RNA in reversible gene regulation. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:12189-12193.
108. Eissmann M., Schwamb B., Melzer I.M., Moser J., Siele D., Kohl U., Rieker R.J., Wachter D.L., Agaimy A., Herpel E., Baumgarten P., Mittelbronn M., Rakel S., Kogel D., Bohm S., Gutschner T., Diederichs S., Zornig M. A functional yeast survival screen of tumor-derived cDNA libraries designed to identify anti-apoptotic mammalian oncogenes. PLoS One 2013, 8.